SFA Therapeutics YC 申请
SFA Therapeutics 在 Summer 2021 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2021
- 行业
- HealthcareTherapeutics
- 团队规模
- 4
- 状态
- Active
- 已发布
- 2021
创始人
Ira SpectorFounder
Alla ArzumanyanFounder
Mark FeitelsonFounder
SFA Therapeutics 做什么
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
SFA Therapeutics 的 YC 申请，重建版
Y Combinator 申请
SFA Therapeutics，Summer 2021 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
We are developing orally-administered immunoregulators targeting chronic inflammation that drives autoimmune diseases and certain cancers. Our drugs block key immune pathways causing diseases like psoriasis, pancreatic cancer, uveitis, and NASH. We already have strong phase 1b clinical data for psoriasis and a pipeline of 9 drug candidates with 15 patents.
We live and are based in Philadelphia, PA, USA. After YC, we plan to stay in Philadelphia to leverage local biotech resources and keep our team intact.
Philadelphia is where our founders are based and where we've built our scientific and clinical collaborations. It has a strong biotech community and is well suited for therapeutic development, so relocating after YC is unnecessary.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 SFA Therapeutics 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 SFA Therapeutics 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 SFA Therapeutics 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
SFA Therapeutics 是哪个 YC 批次的？
SFA Therapeutics 是 Y Combinator Summer 2021 批次的成员。
谁创立了 SFA Therapeutics？
SFA Therapeutics 由 Ira Spector, Alla Arzumanyan, Mark Feitelson 创立。
SFA Therapeutics 做什么？
Regulating the immune system to block cancer & autoimmune diseases
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 SFA Therapeutics 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 SFA Therapeutics
